Sutent Rechallenge In mRCC Patients
NCT01827254
·
clinicaltrials.gov ↗
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Renal Cell Carcinoma
Interventions
OTHER:
sunitinib: observational study
Sponsor
Pfizer